CareDecision Corp. Receives a Significant Equity Stake in DataFuzion Inc. by Closing First Strategic Partnership for Its Medical Software Technologies.

Business Editors

NEW YORK--(BUSINESS WIRE)--Feb. 5, 2004

Merchant Banker Armada Group USA, Inc. Envisions More

Transactions Shortly

CareDecision Corp. (OTCBB:CDED), a leading Wi-Fi PDA technology provider to the lodging and satellite media industries and the developer of patent-pending technologies for e-health and EMR applications, reported today that it has entered into a Strategic Partnership with DataFuzion Inc. ("Fuzion"). Fuzion is a Denver, CO-based medical data warehouse and data mining software application and services provider, and is also a leader in the fast-growing field of medical business intelligence and decision-making tools. This agreement will provide Fuzion access to the CareDecision's PDA based and Wi-Fi medical technologies in return for receipt of a significant equity stake in Fuzion.

Robert Cox, Chairman of CareDecision Corp., commented, "DataFuzion was one of the companies that recently bid to acquire a portion of CareDecision's e-health technologies. When other bidders emerged, our merchant banker adroitly steered discussions toward an equity partnership. This agreement marks the first of several expected near-term transactions involving our medical software technologies. In addition to closing this partnership with us, DataFuzion has decided to file to become a fully-reporting public company, which in the rapidly improving medical information technology markets could greatly enhance the value of our equity stake. For example, a publicly-traded peer company has a market capitalization of approximately $75 million."

Douglas Davis, President and CEO of DataFuzion, Inc., stated, "This agreement is a combination of timing, opportunity and potential -- the necessary ingredients to a successful transaction. Our discussions with CareDecision originated with our examination of their e-health systems, followed by our bid to acquire their technologies. Subsequent conversations facilitated by the Armada Group USA, Inc. persuaded us on the strategic value of a partnership whereby both companies could build shareholder value. CareDecision has realized the value of our enterprise and upon the effective date of our public registration, CareDecision has agreed to distribute to their shareholders most of the equity we are providing as a dividend, with CareDecision shareholders perhaps reaping additional financial benefit under the new tax laws."

Patrick Cole, President of Armada Group USA, Inc., concluded, "We first approached CareDecision with the prospect of the sale of their medical technologies to DataFuzion. During the course of the discussions it became clear that another type of transaction was preferable, one that would allow DataFuzion to accomplish its primary goal of becoming a reporting public company, while at the same time allowing CareDecision to review other offers for its valuable medical technologies. We have taken a big first step with the closing of this transaction and envision additional transactions of this type in the near future."

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. All forward-looking statements are intended to be covered by the safe harbor created by Section 21E of the Securities Exchange Act of 1934.